N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone.

257892-31-2

C17H17N3O3S

343.4

N-desmethyl Rosiglitazone

DMSO:PBS(pH 7.2) (1:3):0.5 mg/mL
Ethanol:1 mg/mL
DMSO:34 mg/mL
DMF:25 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years